The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Data Availability
All data are included in the manuscript
Posted May 19, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (228)
- Allergy and Immunology (506)
- Anesthesia (110)
- Cardiovascular Medicine (1244)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10027)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2462)
- Geriatric Medicine (238)
- Health Economics (479)
- Health Informatics (1645)
- Health Policy (753)
- Hematology (250)
- HIV/AIDS (535)
- Medical Education (253)
- Medical Ethics (75)
- Nephrology (268)
- Neurology (2289)
- Nursing (139)
- Nutrition (352)
- Oncology (1248)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (325)
- Pediatrics (733)
- Primary Care Research (282)
- Public and Global Health (4840)
- Radiology and Imaging (838)
- Respiratory Medicine (651)
- Rheumatology (286)
- Sports Medicine (227)
- Surgery (268)
- Toxicology (44)
- Transplantation (125)
- Urology (99)